Schizophrenia In Teenagers

Featured Article

This is a study to evaluate the long-term safety and effectiveness of Invega XR, given in flexible doses, to teens with schizophrenia. This national study is currently recruiting teens ages 12 years to 17 years old who have this condition.

Read more

More information on "Schizophrenia In Teenagers"

From Our Experts

See more SharePosts »

From Our Sources

More on Schizophrenia »